A Phase 1 Multicenter Study of Three Escalating Doses of hMaxi-K Gene Transfer in Female Participants With Overactive Bladder Syndrome and Detrusor Overactivity.
Phase of Trial: Phase I
Latest Information Update: 21 Mar 2012
At a glance
- Drugs Maxi-K gene therapy (Primary)
- Indications Overactive bladder
- Focus Adverse reactions
- Sponsors Ion Channel Innovations
- 21 Mar 2012 Actual patient number is 21 according to ClinicalTrials.gov.
- 21 Mar 2012 Actual end date (Nov 2009) added as reported by ClinicalTrials.gov.
- 21 Mar 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.